Segment Information (Tables)

6 Months Ended

Jun. 30, 2020

Selected Financial Info by Reportable Segment

Selected financial information by reportable segment is presented below (in thousands):


	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Revenues, net:
Prescription Pharmaceuticals	$	104,424	$	158,379	$	283,668	$	306,394
Consumer Health	15,886		19,678		41,335		37,534
Total revenues, net	120,310		178,057		325,003		343,928

Gross Profit:
Prescription Pharmaceuticals	21,247		59,785		98,407		105,228
Consumer Health	9,805		8,199		27,189		16,269
Total gross profit	31,052		67,984		125,596		121,497

Operating expenses	86,930		155,350		428,392		274,346

OPERATING (LOSS)	(55,878)		(87,366)		(302,796)		(152,849)

Other expenses, net	(38,548)		(22,751)		(71,802)		(38,029)

(Loss) before income taxes	$	(94,426)	$	(110,117)	$	(374,598)	$	(190,878)

Revenue from External Customers by Geographic Areas

The following table sets forth the Company’s net revenues by geographic region for the three and six month periods ended June 30, 2020 and 2019. The Domestic region represents sales within the United States of America and its territories while the Foreign region represents sales within all other countries and territories (dollar amounts in thousands):


	Three Months Ended June 30, 2020					Three Months Ended June 30, 2019				Six Months Ended June 30, 2020			Six Months Ended June 30, 2019
Region	Amount		% of Total Revenues	Amount		% of Total Revenues	Amount		% of Total Revenues	Amount		% of Total Revenues
Domestic	$	119,212	99.1%	$	174,109	97.8%	$	321,045	98.8%	$	338,243	98.3%
Foreign	1,098		0.9%	3,948		2.2%	3,958		1.2%	5,685		1.7%
Total Revenues	$	120,310	100.0%	$	178,057	100.0%	$	325,003	100.0%	$	343,928	100.0%